Arbutus Biopharma Corp

Arbutus Biopharma Corp is a biopharmaceutical company focused on developing innovative therapies for serious viral infections. Its primary aim is to address the significant unmet medical needs of patients affected by chronic viral diseases through advanced research.The company operates in the USA and Canada. Operating within the biotechnology and healthcare sectors, Arbutus Biopharma Corp concentrates on discovering and advancing novel treatment candidates. Its research programmes are designed to develop therapies that can potentially cure or significantly improve the management of chronic viral infections, ultimately enhancing patient health. Monitor the ABUS share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.